1. Home
  2. CETX vs REVB Comparison

CETX vs REVB Comparison

Compare CETX & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$2.65

Market Cap

4.6M

Sector

Technology

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.07

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
REVB
Founded
1998
2020
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
3.9M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
CETX
REVB
Price
$2.65
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.2K
29.3K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.68
EPS
N/A
N/A
Revenue
$120,628,200.00
N/A
Revenue This Year
$20.41
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.73
N/A
52 Week Low
$0.37
$0.47
52 Week High
$9.70
$2.90

Technical Indicators

Market Signals
Indicator
CETX
REVB
Relative Strength Index (RSI) 45.81 49.38
Support Level $2.43 $0.95
Resistance Level $3.21 $1.11
Average True Range (ATR) 0.16 0.08
MACD -0.02 -0.00
Stochastic Oscillator 20.62 26.70

Price Performance

Historical Comparison
CETX
REVB

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: